Compounds > pyrroles

Page last updated: 2024-08-18

pyrroles and Polymyositis

pyrroles has been researched along with Polymyositis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atas, N; Babaoglu, H; Salman, R; Satis, H; Tufan, A; Varan, O	1
Flores, RM; Kanth, R; Shah, MS	1
Famularo, G; Gasbarrone, L; Minisola, G	1

Other Studies

3 other study(ies) available for pyrroles and Polymyositis

Article	Year
Tofacitinib for the Treatment of Refractory Polymyositis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2019, Volume: 25, Issue:8 Topics: Antirheumatic Agents; Biopsy; Disease Progression; Drug Resistance, Multiple; Electromyography; Female; Humans; Janus Kinase Inhibitors; Medication Therapy Management; Middle Aged; Monitoring, Immunologic; Muscle Strength; Muscle Weakness; Piperidines; Polymyositis; Pyrimidines; Pyrroles; Treatment Outcome	2019
Statin-associated polymyositis following omeprazole treatment. Clinical medicine & research, 2013, Volume: 11, Issue:2 Topics: Anticholesteremic Agents; Atorvastatin; Drug Interactions; Esophagitis; Gemfibrozil; Heptanoic Acids; Humans; Male; Methotrexate; Middle Aged; Myocardial Infarction; Omeprazole; Polymyositis; Prednisone; Proton Pump Inhibitors; Pyrroles; Treatment Outcome; Withholding Treatment	2013
Comment and reply on: Atorvastatin: safety and tolerability. Statins and polymyositis: a neglected link? Expert opinion on drug safety, 2010, Volume: 9, Issue:6 Topics: Atorvastatin; Autoimmune Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Polymyositis; Pyrroles	2010